Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice

Autor: Jenevieve D’souza, Pritishkumar Tidke, Sophiya Siddiqui, Indraneel Mittra, Kavita Pal, Vishal Jadhav, Bhagyeshri Rane, Saili Parab, Namrata Pancholi, Gorantla V. Raghuram, Sushma Shinde, Alfina Shaikh, Soniya Shende
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Lipopolysaccharides
Hydrolases
Physiology
Apoptosis
030204 cardiovascular system & hematology
Pathology and Laboratory Medicine
Biochemistry
Histones
Mice
0302 clinical medicine
Immune Physiology
Medicine and Health Sciences
Immune Response
Innate Immune System
Multidisciplinary
Deoxyribonucleases
biology
Cell Death
Chemistry
Chromatin
Enzymes
Nucleic acids
medicine.anatomical_structure
Cell Processes
Cytokines
Medicine
Female
medicine.symptom
Antibody
Inflammation Mediators
Cell-Free Nucleic Acids
Research Article
Programmed cell death
DNA damage
Nucleases
Science
Immunology
Spleen
Inflammation
Microbiology
Proinflammatory cytokine
Sepsis
03 medical and health sciences
Signs and Symptoms
Diagnostic Medicine
Virology
DNA-binding proteins
medicine
Genetics
Animals
Deoxyribonuclease I
Host Cells
Biology and Life Sciences
Proteins
Cell Biology
DNA
Molecular Development
medicine.disease
Endotoxins
Mice
Inbred C57BL

030104 developmental biology
Resveratrol
Immune System
biology.protein
Enzymology
Nanoparticles
Viral Transmission and Infection
Copper
Developmental Biology
Zdroj: PLoS ONE, Vol 15, Iss 3, p e0229017 (2020)
PLoS ONE
ISSN: 1932-6203
Popis: We have earlier reported that cell-free chromatin (cfCh) particles that are released from dying cells, or those that circulate blood, can readily enter into healthy cells, illegitimately integrate into their genomes and induce dsDNA breaks, apoptosis and intense activation of inflammatory cytokines. We hypothesized that sepsis is caused by cfCh released from dying host cells following microbial infection leading to bystander host cell apoptosis and inflammation which are perpetuated in a vicious cycle with release of more cfCh from dying host cells. To test this hypothesis we used three cfCh inactivating agents namely 1) anti-histone antibody complexed nanoparticles which inactivate cfCh by binding to histones; 2) DNase I which inactivates cfCh by degrading its DNA component, and 3) a novel pro-oxidant combination of Resveratrol and Copper which, like DNase I, inactivates cfCh by degrading its DNA component. Female C57 BL/6 mice, 6-8 weeks old, were administered a single i.p. injection of LPS at a dose of 10 mg/Kg or 20 mg/Kg with or without concurrent treatment with the above cfCh inactivating agents. Administration of cfCh inactivating agents concurrently with LPS resulted in prevention of following pathological parameters: 1) release of cfCh in extra-cellular spaces of brain, lung and heart and in circulation; 2) release of inflammatory cytokines in circulation; 3) activation of DNA damage, apoptosis and inflammation in cells of thymus, spleen and in PBMCs; 4) DNA damage, apoptosis and inflammation in cells of lung, liver, heart, brain, kidney and small intestine; 5) liver and kidney dysfunction and elevation of serum lactate; 6) coagulopathy, fibrinolysis and thrombocytopenia; 7) lethality. We conclude that cfCh that are released from dying host cells in response to bacterial endotoxin represents a global instigator of sepsis. cfCh inactivation may provide a novel approach to management of sepsis in humans.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje